These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 8574725

  • 1. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
    Berenguer M, Olaso V, Córdoba J, Gobernado M, Carrasco D, Berenguer J.
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
    García-Bengoechea M, Basaras M, Barrio J, Arrese E, Montalvo II, Arenas JI, Cisterna R.
    Am J Gastroenterol; 1999 Jul; 94(7):1902-5. PubMed ID: 10406257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
    Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, Efremov DG, Burrone O, Santini G, Pozzato G.
    Cancer; 1996 Jun 15; 77(12):2604-13. PubMed ID: 8640712
    [Abstract] [Full Text] [Related]

  • 8. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G.
    Ital J Gastroenterol Hepatol; 1997 Aug 15; 29(4):343-50. PubMed ID: 9476189
    [Abstract] [Full Text] [Related]

  • 9. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
    Davis GL, Lau JY.
    J Hepatol; 1995 Aug 15; 22(1 Suppl):110-4. PubMed ID: 7602061
    [Abstract] [Full Text] [Related]

  • 10. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK, Davis GL, Wu SP, Gish RG, Balart LA, Lau JY.
    Hepatology; 1996 Jun 15; 23(6):1318-23. PubMed ID: 8675145
    [Abstract] [Full Text] [Related]

  • 11. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB.
    Am J Gastroenterol; 1997 Jan 15; 92(1):73-8. PubMed ID: 8995941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
    Chang TT, Young KC, Yang YJ, Lei HY, Wu HL.
    Hepatology; 1996 May 15; 23(5):977-81. PubMed ID: 8621178
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.
    Larghi A, Tagger A, Crosignani A, Ribero ML, Bruno S, Portera G, Battezzati PM, Maggioni M, Fasola M, Zuin M, Podda M.
    J Med Virol; 1998 May 15; 55(1):7-11. PubMed ID: 9580879
    [Abstract] [Full Text] [Related]

  • 16. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
    Zaghloul H, El-Sherbiny W.
    Immunol Invest; 2010 Jan 15; 39(3):284-91. PubMed ID: 20380524
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Jan 15; 27(5):319-24. PubMed ID: 8588128
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C, Poovorawan Y, Sura T, Theamboonlers A, Busagorn N, Kurathong S.
    Southeast Asian J Trop Med Public Health; 1998 Sep 15; 29(3):480-90. PubMed ID: 10437943
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J.
    Rev Esp Enferm Dig; 1997 Jul 15; 89(7):531-50. PubMed ID: 9265839
    [Abstract] [Full Text] [Related]

  • 20. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M, Ken A, Okuno T.
    Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.